Skip to content
    Gaingels logo

    Gaingels

    Burlington, United StatesFounded 2014

    Gaingels is a venture investment syndicate and one of the largest LGBTQIA+/Allies venture investors in the world, co-investing in companies with diverse and underrepresented leadership. Founded in 2014 and headquartered in Burlington, Vermont, the firm invests across all sectors and stages from pre-seed to pre-IPO, having deployed over $1 billion across more than 2,600 portfolio companies.

    Average disclosed round size is $31.6M (across 572 rounds with reported amounts).

    Find people at Gaingels on Goldilocks AI

    Portfolio

    499

    Fund Size

    —

    Top Stage

    Seed

    Last 12 Mo

    32

    Team

    PG

    Paul Grossinger

    Co-founder & General Partner

    PS

    Peter Steinberg

    Managing Partner

    JJ

    Jennifer Jeronimo

    General Partner

    LT

    Lorenzo Thione

    Managing Director

    PV

    Philip Veber

    Principal

    IE

    Iman El-Hassan

    VC

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    620 investments
    CompanyRoundAmountDate
    HHooraySeed$2MAug 2026
    Cryopets logoCryopetsUnknown$2MAug 2026
    Dawn Aerospace logoDawn AerospaceSeries B$25MJun 2026
    Forage logoForageSeries B$40MJun 2026
    THEA logoTHEASeries B$100MMay 2026
    hellbender logohellbenderSeed$12.5MMay 2026
    Overplay logoOverplaySeed$3MMay 2026
    Hybron logoHybronSeed$25MApr 2026
    SStarfishSeries B$100MApr 2026
    Stake logoStakeSeries A$8MMar 2026
    Nitra logoNitraSeries B$50MMar 2026
    RenoFi logoRenoFiSeries B$22MMar 2026
    Ando Foods logoAndo FoodsSeed$4MFeb 2026
    RAPIDFORT logoRAPIDFORTSeries A$42MFeb 2026
    Emobi logoEmobiSeed$3.4MJan 2026
    Neurophos logoNeurophosSeries A$110MJan 2026
    LLuminate MedicalSeries A$17.5MJan 2026
    Cambium logoCambiumSeries B$100MJan 2026
    CCambium BiomaterialsSeries B$100MJan 2026
    Ampaire logoAmpaireSeries B$19MJan 2026
    Latus Bio logoLatus BioSeries A$54MJan 2026
    Alloy Therapeutics logoAlloy TherapeuticsSeries E$40MJan 2026
    Ampaire logoAmpaireSeries B$19MJan 2026
    Hone Health logoHone HealthSeries A$33MJan 2026
    Ethermed logoEthermedSeries A$8.5MJan 2026
    Page 1 of 25

    Top Co-Investors

    SV Angel75 shared
    Y Combinator45 shared
    8VC33 shared
    Techstars27 shared
    Greycroft24 shared
    Founders Fund23 shared
    FJ Labs15 shared
    QED Investors13 shared
    Soma Capital12 shared
    GV12 shared

    Last updated: 7 October 2026